Multiple sclerosis (MS) is an inflammatory disease defined by damage to the myelin sheaths of neurons. MS is classified into different subtypes including relapsing-remitting MS, secondary progressive MS and primary progressive MS. The present study aimed to estimate the prevalence of different forms and clinical symptoms of MS among Iranian people using meta-analysis. We searched all available databanks, such as SID, Magiran, PubMed, Google scholar, Scopus and Science, directly to identify relevant evidence. All findings were reviewed and eligible articles were selected. The standard error of prevalence was calculated based on binomial distribution formula. The heterogeneity between the results of primary studies was detected using Cochrane (Q) and I 2 indices. The primary results were combined according to a random effects model. The effect of related factors in heterogeneity was investigated using a meta-regression model. During the primary search, 17 352 articles were identified. After limiting the search strategy, and excluding duplicates and irrelevant papers, finally, 21 primary studies were entered into the final meta-analysis. The total prevalences of relapsingremitting MS, primary progressive MS and secondary progressive MS types among Iranian people were estimated to be 69.7% (95% CI 63.7-75.8), 7.01% (95% CI 4.05-9.96) and 17.8% (95% CI 11.7-23.9) respectively. In addition, prevalences of fatigue and motor dysfunction were estimated to be 71.1% (95% CI 60.9-81.3) and 56.3% (95% CI 27.9-84.6), respectively. Our meta-analysis showed that relapsing-remitting MS is the most common type of MS, and fatigue is the most common clinical manifestation in patients. Motor dysfunction and balance disorder are the other common problems in patients.
Introduction
Multiple sclerosis (MS) is an inflammatory disorder characterized by progressive demyelination of the brain and spinal cord. 1 MS has a complicated etiology, and is defined by different subtypes including relapsing-remitting (RR), secondary progressive (SP) and primary progressive (PP). The most common subtype of MS (85-90%) is the RR subtype, which is higher among women. If this type develops to progressive neurological relapse between the attacks, the MS subtypes is SP subtype. The PP subtype, which is more common among older men, is characterized by no remission after the initial symptoms. 2 Furthermore, MS presents with various symptoms and neurological deficits, such as urinary dysfunction, 3 visual disturbances, 4 sexual dysfunction 5 depression, 6 fatigue 7 and reduction in physical activity behavior. 8 Approximately 80% of patients complain of gait problems as a result of muscle weakness or spasticity, fatigue and balance impairments within 10-15 years of disease onset. 9 Traditionally, symptoms of MS can be categorized as: symptoms occur due to central nervous system demyelination called primary symptoms; symptoms resulting from the primary manifestations called secondary symptoms (bladder dysfunction leads to infections); and tertiary symptoms are those that occur because of psychological reactions to stress. 10 It is believed that the type of initial symptoms affects the disease prognosis; for example, sensory symptoms will be diagnosed more easily than cerebellar or motor involvement at the beginning of the disease. 2 In contrast, clinical manifestation of MS might differ geographically. Previously, Iran has been considered to be a low-risk region for MS; however, according to a prevalence of 43.8 out of 100 000 and an incidence of 3.64 out of 100 000 in Isfahan province in Iran in 2007, this country can be listed among medium-to high-risk countries for MS. 11, 12 To our knowledge, several primary studies regarding the subtypes and the common clinical symptoms of MS among the Iranian population have been published that provide a great opportunity for combining these studies and estimating a valid prevalence using a meta-analysis method. The present study aimed to identify the prevalence of different subtypes of MS and the most common clinical symptoms in patients with MS in Iran using a metaanalysis approach.
Methods

Picots
The present study was designed based on the PRISMA checklist. The study population was Iranian patients with MS, our final outcomes were subtypes of MS (RRMS, PPMS, progressive-relapsing MS) and the most common clinical symptoms (reduced visual, sensory, motor, balance, urinary, bowel movements, fatigue), time duration was from 2000 to 31 December 2016, and all cohorts and descriptive studies were included.
Search strategy
To find electronic papers, Persian (SID, Magiran) and international (PubMed, Google scholar, Scopus and Science direct) data banks were searched using the following keywords, their Farsi equivalents and the time duration from 2000 to 31 December 2016:
"prevalence", "frequency ", "multiple sclerosis", " MS", "clinical", "difficulty", "dysfunction", "symptoms", "walking", "reduced visual", "sexual" "bowel dysfunction", "fatigue", "sensory" "motor", "facial motor", "facial sensory" "speech", "swallowing", "mental deterioration" "relapsing-remitting", "secondary progressive", "primary progressive" "progressive-remitting" and "RRMS". The Search was carried out between 20 and 31 January 2016 by two independent researchers. Furthermore, all references of the papers were investigated to identify more relevant articles. A third researcher randomly evaluated the search results to find any ignored evidence. The researchers also looked for non-electronic papers and interviewed with relevant experts, as well as research centers to identify any grey literature.
Study selection
Full texts or abstracts of all studies identified during the comprehensive search were extracted. At first, duplicates were excluded. Then, titles, abstracts and full texts were investigated to find and remove irrelevant papers. Researchers also reviewed all results of the primary studies in detail to find any probable repeated findings.
Quality assessment
All papers selected during the previous steps were quality assessed using a checklist designed according to the STROBE contents. 13 This checklist included 22 questions regarding various parts of studies, such as sample size and sampling methods, study design and study population, methods and instruments for data collection, variable definition, statistical methods, study objectives, and illustration of the results. Each study was assigned a score from zero to 44, then all studies were categorized into low quality (less than 15.5), moderate quality (15.5-29.5) and high quality (30-44). We excluded low-quality studies from the final analysis.
Data extraction
Required information was extracted from each study including the title, first author's name, study date, sample size, type of study, sampling method, mean age of patients and frequencies of different types of MS. This information was entered into Excel spreadsheets.
Inclusion criteria
All studies that were written in Persian or English, obtained at least 15.5 quality scores and reported frequencies of different clinical symptoms of MS were included in the meta-analysis.
Exclusion criteria
Case reports, case series, abstracts presented in congresses without full text, studies that did not report MS prevalence or its manifestations and studies that did not report sample size were excluded from the meta-analysis.
Statistical analysis
Stata SE version 11 software (StataCorp, College Station, TX, USA) was used for data analysis. The standard error of prevalence was calculated based on the binomial distribution formula. The heterogeneity between the results of primary studies was measured using Cochrane (Q) test and I 2 index. Because of significant heterogeneity, a random effects model was applied for combining the point prevalences. The effect of suspicious factors in heterogeneity was investigated using meta-regression models. All point prevalences with 95% confidence intervals (crossed lines) were illustrated by forest plots.
Results
During primary search, 17 352 articles were identified. Limiting the search strategy, 1968 papers remained. Of them, 1025 duplicates and 750 irrelevant papers were excluded. A full text review detected 170 irrelevant papers. A reference review added two new articles to the results. After applying inclusion/exclusion criteria and quality assessment, four papers were omitted. Finally, 21 primary studies were entered into the final meta-analysis (Fig. 1) .
Primary studies were published from 2003 to 2015. Eight of which were written in English. The type of study was specified in 13 papers, all of them were cross-sectional. Sampling methods were reported in eight papers, including random (three studies), consensus (four studies) and convenience (one study) sampling. The mean age of participants was reported in 14 studies and the range was 28.4-44.6 years. Sample size was <100 in five studies, 100-203 in eight studies and >500 in eight studies.
The female-to-male ratio among MS patients differed between 2.6 to 6.4 ( Table 1 ). The prevalence of RRMS was reported in nine studies and the range was 56.7-83.3%. The total prevalence of progressive-relapsing MS among Iranian patients was estimated to be 69.7% (95% confidence interval 63.7-75.8; Fig. 2 ). The prevalence of PPMS was investigated in seven studies and the range was 1.1-23.30%. The pooled prevalence of PPMS was estimated to be 7.01% (95% confidence interval 4.05-9.96; Fig. 3 ). Among six studies reporting the prevalence of SPMS, the prevalence of this type of MS was reported to be 11.2-28%. The total prevalence of SPMS was estimated to be 17.8% (range 11.7-23.9; Fig. 4 ). According to the results of the 12 studies reporting the prevalence of visual impairment among MS patients, 13-80.4% of patients complained of this problem, indicating a pooled prevalence of 44.3% (95% confidence interval 33.6-55.01; Fig. 5 ). Sensory problems were reported in nine studies, ranging 24.5-73.3%. Using meta-analysis, the prevalence of sensory problems among Iranian MS patients was estimated to be 41.2% (95% confidence interval 30.1-52.3; Fig. 6 ). In addition, other complications, such as motor, balance, urinary and defecation problems, and fatigue syndrome, are presented in Table 2 . Zandieh (2013) Izadi (2015) Mazaheri (2007 Zandieh (2013) Maghzi (2007) Abedini (2008) Mazaheri (2007) 7.01 (4.05, 9.96) Using meta-regression models, the mean age of the study population and the date the study was carried out did not significantly influence the heterogeneity.
Discussion
The results of the present study showed that RRMS was the most common subtype of MS among the Iranian population. SPMS and PPMS, respectively, were the next most common subtypes. The clinical course of MS is very heterogeneous, 14 Other studies also reported that RRMS accounts for 85-90% of individuals with MS, and is also more common in women than men. RRMS is characterized by episodes of acute worsening of function followed by partial or complete recovery. 2, 14 When a patient's clinical condition has deteriorated independent of relapses, SPMS has developed. 15 Compared with other subtypes of MS, SPMS has an unfavorable prognosis and patients experience severe dysfunction. 15 The PP subtype is characterized by rapid progression of the disease and affects approximately 10-15% of MS patients. This subtype is more common in men than women. 2, 14 The findings of the study showed that fatigue, which is difficult to treat, is the most common clinical manifestation among these patients. Motor dysfunction and balance disorder are the other common problems experienced by patients. 10, 16 Fatigue in MS is defined as an abnormal feeling of tiredness or lack of energy, disproportionate to the degree of effort or level of disability, that significantly interferes with routine physical or intellectual functioning. 17 Fatigue has been reported by 75-90% of patients. 18, 19 The Zandieh (2013) Mazaheri (2007) Hashemilar (2011) Abedini (2008 Maghzi (2007) Mohammadkhani (2003) Abedini (2008) Nabavi (2006) Rezaali (2013) Mazaheri (2007 etiology of fatigue in MS is unknown. It is believed that peripheral and central mechanisms play a role in fatigue. 18 In addition, fatigue can affect quality of life independent of depression or disability, and is considered to be one of the most debilitating symptoms, surpassing pain and even physical disability. 19 Balance problems and falling are common among people with MS, but their cause is not well understood. It is known that MS affects many areas of the central nervous system that can affect postural responses to balance maintenance, including the cerebellum and the spinal cord. 20 Poor balance control in patients might be due to impairments in cognitive, visual, vestibular, motor, sensory and/or coordination functions, and the contributions of each of these factors differ among individuals. 21 Some of the clinical symptoms of MS are easily treatable, some are harder to treat and some others are very difficult to treat. For example, the bowel is less affected than the bladder. However, if incontinence occurs, it causes embarrassment. Additionally, fatigue is the most common symptom of MS and is often difficult to treat. 10 The findings of the present study showed that focusing on fatigue as the most common symptom of these patients can improve their quality of life.
As a limitation of the present study, there are other clinical symptoms experienced by patients with MS that were not reported in the primary studies entered into the current meta-analysis.
The present meta-analysis showed that RRMS is the most common type of MS and fatigue is the 81.9 Figure 6 Prevalence of sensory impairment among Iranian multiple sclerosis patients (primary and pooled estimates). most common clinical manifestation in these patients. Motor dysfunction and balance disorder are the other common problems that should be taken into consideration.
